Iovance Biotherapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:IOVA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -205.13 M-227.94 M-292.76 M-361.82 M-352.98 M-302.41 M -270.79 M Cash from investing activities -317.85 M132 K256.45 M-155.24 M-96.41 M47.5 M 43.02 M Cash from financing activities 576.42 M239.27 M190.15 M462.96 M390.66 M300.77 M 251.79 M Free cash flow -205.13 M-227.94 M-292.76 M-361.82 M-352.98 M-302.41 M -270.79 M

News

Replimune: Stock Buoyant On Third Try At RP1 Approval - FDA AdCom May Be Crucial (REPL)

Iovance Biotherapeutics: Progress With Caveats (NASDAQ:IOVA)

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Undercovered Stocks: Western Digital, SAP, Toast And More

Pacira (PCRX) Q1 Earnings Miss Estimates

Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release